BridgeBio Pharma, Inc.

$2.8M revenue • United States

Last Updated Dec 22, 2025

Company Overview

Company Name

BridgeBio Pharma, Inc.

Address

United States

Approx. Annual Revenue

$2.8M

Established

2018

About BridgeBio Pharma, Inc.

Calcilytix is a company based in the United States that was established in 2018. The company's website indicates a focus on security and performance, suggesting they may provide technology-related services or products. However, without further information, a comprehensive overview cannot be provided.

Frequently Asked Questions about BridgeBio Pharma, Inc.

Technologies Used

Social Profiles

Key Decision Makers

Neil Kumar CEO and Founder
LinkedIn
Arun Mathew Executive Director, Medical Affairs
LinkedIn
Debra Jones Clinical Trial Manager
LinkedIn